← All diseases Cancer

Non-Hodgkin lymphoma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (62)Meta-analysis (19)Treatment guideline (5)Systematic review (21)Randomized trial (9)Phase 3 study (8)Clinical trial (628)Review article (211)Early study (phase 1 or 2) (53)Description of several patients (388)Laboratory or animal study (21)Commentary or editorial (27) Studies currently seeking participants only (48)

Filter

Publications and studies (2186)

• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. [The guideline of the diagnosis and treatment of mantle cell lymphoma in China (2022)]. (2022/07/14) ♡
• [Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma]. (2022/07/14) ♡
• [The expressional characteristics and diagnostic values of TRBC1 in mature T-cell lymphoma]. (2022/07/14) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Follicular T-cell lymphoma: a case report]. (2022/07/14) ♡
• Management of elderly patients with malignant lymphoma. (2022/07/08) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Peritoneal lymphomatosis. A case report. (2022/07/01) ♡
• Impact of Frailty on Hospital Outcomes Among Patients with Lymphoid Malignancies Receiving Autologous Hematopoietic Stem Cell Transplantation in the United States. (2022/07/01) ♡
• Long-Term Clinical Outcomes and Sequelae of Therapy in Early-Stage Orbital Mucosa-Associated Lymphoid Tissue Lymphoma. (2022/07/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Results from a Phase 1b Study. (2022/07/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective. (2022/07/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study. (2022/07/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study. (2022/07/01) ♡
• Decision criteria for resource allocation: an analysis of CONITEC oncology reports. (2022/07/01) ♡
• Gastric MALT Lymphoma: A 8-Year Experience. (2022/07/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies. (2022/07/01) ♡
• The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma. (2022/07/01) ♡
• Radiation Therapy for Mantle Cell Lymphoma with Orbital Involvement. (2022/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hepatic Angiosarcoma Post-Renal Transplantation: A Case Report. (2022/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Covid-19 presenting as isolated severe thrombocytopenia in an HIV-lymphoma survivor. (2022/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. (2022/06/30) ♡
• Environmental risk factors for non-Hodgkin's lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data. (2022/06/27) ♡
• Estrogen Receptor β (ESR2) Transcriptome and Chromatin Binding in a Mantle Cell Lymphoma Tumor Model Reveal the Tumor-Suppressing Mechanisms of Estrogens. (2022/06/24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prognostic impact of the controlling nutritional status score in patients with peripheral T-cell lymphoma. (2022/06/01) ♡
• Chylotamponade in Pediatric Primary Mediastinal Large B-Cell Lymphoma. (2022/06/01) ♡
• Diffuse large B cell lymphoma and a novel gammaherpesvirus in northern elephant seals Mirounga angustirostris. (2022/05/24) ♡
• Selected Domains within a Comprehensive Geriatric Assessment in Older Patients with Non-Hodgkin Lymphoma are Highly Associated with Frailty. (2022/05/11) ♡
• Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. (2022/05/10) ♡
• Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas. (2022/05/09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma. (2022/05/05) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Symptomatic Thyroglossal Duct Cyst Presenting With Synchronous and Localized Tongue Base Extranodal Mantle Cell Lymphoma. A Unique Case Report Demonstrating Lymphoma Colonization of Cyst Wall, Potentially Relating to a Persistent Embryological Foramen Cecum Remnant. (2022/05/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Advanced-Stage CD30(+) Mycosis Fungoides Treated With Brentuximab. (2022/05/01) ♡
• Alpha-tocotrienol enhances arborization of primary hippocampal neurons via upregulation of Bcl-xL. (2022/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Assessing frailty using comprehensive geriatric assessment in older patients with hematologic malignancy. (2022/04/30) ♡
• The Analysis of Human Epidermal Growth Receptor-2 (HER-2) in Gastric Cancer in a Tertiary Hospital in Sub-Saharan Africa. (2022/04/28) ♡
• A single-cell atlas of diffuse large B cell lymphoma. (2022/04/19) ♡
• Ocular adnexal lymphoma: A single-institution retrospective study. (2022/04/18) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36. (2022/04/18) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The Sandwich Sign in Small Lymphocytic Lymphoma. (2022/04/01) ♡
• Clinicopathologic significance of DNA replication licensing factors in head and neck diffuse large B-cell lymphoma. (2022/04/01) ♡
• Clinico-Epidemiological Profile, Prognostic Factors and Treatment Outcome of Refractory Hodgkin Lymphoma. (2022/04/01) ♡
• The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma. (2022/04/01) ♡
• Refining measurement of swallowing safety in the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) criteria: Validation of DIGEST version 2. (2022/04/01) ♡
• Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma. (2022/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case of Pulmonary Hypertension in a 67-Year-Old Woman with Thiamine Deficiency Following Partial Gastrectomy and Exacerbated by Diuretics. (2022/03/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Jejunocolic fistula presenting as chronic diarrhoea from advanced lymphoma. (2022/03/03) ♡
• Optic Perineuritis in Waldenström Macroglobulinemia-Related Cryoglobulinemic Vasculitis. (2022/03/01) ♡
• The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition. (2022/03/01) ♡
• Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group. (2022/03/01) ♡
• Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma. (2022/02/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Positron Emission Tomography Molecular Imaging for Phenotyping and Management of Lymphoma. (2022/02/24) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.